American Cryostem Corp (CRYO) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2013

American Cryostem Corp

CIK: 1468679 Ticker: CRYO
Document And Entity Information (USD $)
12 Months Ended
Sep. 30, 2013
Mar. 29, 2013
Jan. 07, 2013
Document and Entity Information [Abstract]      
Entity Registrant Name AMERICAN CRYOSTEM Corp    
Entity Central Index Key 0001468679    
Trading Symbol cryo    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-Known Seasoned Issuer No    
Current Fiscal Year End Date --09-30    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock, Shares Outstanding     32,574,221
Entity Public Float   $ 2,065,919  
Document Type 10-K    
Document Period End Date Sep. 30, 2013    
Amendment Flag false    
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    

View differences made from one year to another to evaluate American Cryostem Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Cryostem Corp.


Assess how American Cryostem Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets (audited)
Consolidated Balance Sheets (audited) (parentheticals)
Consolidated Statements Of Cash Flows (audited)
Consolidated Statements Of Operations (audited)
Statements Of Changes In Shareholders' Equity
Administration Expense
Administration Expense (tables)
Administration Expense - Summary Of Administrative Expenses (details)
Commitments & Contingencies
Commitments & Contingencies (detail Textuals)
Commitments & Contingencies (tables)
Commitments & Contingencies - Table Of Minimum Lease Payments Due On Capital Leases (details)
Common Stock Issuances
Common Stock Issuances (detail Textuals)
Debt (detail Textuals)
Debt (tables)
Debt - Summary Of Debt Outstanding (details)
Equipment (detail Textuals)
Equipment (tables)
Equipment - Summary Of Equipment (details)
Fair Values Of Financial Instruments
Going Concern
Loss Per Share
Loss Per Share (detail Textuals)
Loss Per Share (tables)
Loss Per Share - Summary Of Net Loss Per Share (details)
Option Issuances
Option Issuances (detail Textuals)
Option Issuances (tables)
Option Issuances - Summary Of Common Stock Options Outstanding (details 1)
Option Issuances - Summary Of Fair Value Measurements For Share-based Compensation (details)
Organization Of The Company And Significant Accounting Policies
Organization Of The Company And Significant Accounting Policies (detail Textuals)
Organization Of The Company And Significant Accounting Policies (policies)
Organization Of The Company And Significant Accounting Policies (tables)
Organization Of The Company And Significant Accounting Policies - Summary Of Estimated Useful Life (details)
Reliance On Key Personnel
Subsequent Events

Material Contracts, Statements, Certifications & more

American Cryostem Corp provided additional information to their SEC Filing as exhibits

Ticker: CRYO
CIK: 1468679
Form Type: 10-K Annual Report
Accession Number: 0001019056-14-000025
Submitted to the SEC: Tue Jan 14 2014 12:27:01 PM EST
Accepted by the SEC: Tue Jan 14 2014
Period: Monday, September 30, 2013
Industry: Health And Allied

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: